From: Safety of licensed vaccines in HIV-infected persons: a systematic review protocol
Antigen | Children | Adolescents | Adults |
---|---|---|---|
BCG | Â | Â | Â |
Hepatitis B | 3–4 doses | 3 doses for high-risk groups if not previously vaccinated | |
Polio | 3–4 doses |  |  |
DTP | 3 doses, booster (DTP), 1–6 years of age | Booster | Booster |
Haemophilus influenzae type b (Hib) | 3 doses with DTP | Â | Â |
Pneumococcal (conjugate) | 3 doses with DTP | Â | Â |
Rotavirus | 2 or 3 doses with DTP | Â | Â |
Measles | 2 doses | Â | Â |
Rubella | 1 dose | 1 dose, adolescent girls if not previously vaccinated | |
HPV | 3 doses | Girls | Â |
Japanese encephalitis | 1 dose, booster dose after 1 year | Booster dose after every 3 years up to 10–15 years of age |  |
Yellow fever | 1 dose | Â | Â |
Tick-borne encephalitis | 3 doses | Â | Â |
Typhoid | 1 dose or 3 doses (dependent on vaccine), booster dose after 3–7 years | ||
Cholera | 3 doses with booster after every 6Â months, 2 doses for children of 6Â years and older/adults with booster every 2nd year | ||
Meningococcal | 1 dose (1–29 years) | ||
Men A conjugate | 2 doses (2–11 months) with booster 1 year after 1st dose | ||
Men C conjugate | 2 doses (9–23 months), 1 dose (2 years and older) | ||
Quadrivalent conjugate | Â | ||
Hepatitis B | At least 1 dose at 1Â year or older | ||
Rabies | 3 doses | ||
Mumps | 2 doses | Â | Â |
Influenza (inactivated) | 2 doses, revaccinate annually | 1 dose from 9Â years of age, revaccinate annually |